收藏切换
Optimized Synthesis of Asciminib Hydrochloride
收藏切换
Xinyu LU1, 2, 3, Yang ZHOU1, 2, 3, Zhaoping XIA1, 2, 3, Guan WANG1, 2, 3, *
Chinese Journal of Pharmaceuticals | 2025, 56(11) : 1398 - 1403
Less
收藏切换
Chinese Journal of Pharmaceuticals | 2025, 56(11): 1398-1403
• Paper •
Optimized Synthesis of Asciminib Hydrochloride
Full
Xinyu LU1, 2, 3, Yang ZHOU1, 2, 3, Zhaoping XIA1, 2, 3, Guan WANG1, 2, 3, *
Affiliations
  • 1.National Key Lab. of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry Co., Ltd., Shanghai 201203
  • 2.China State Institute of Pharmaceutical Industry, Shanghai 201203
  • 3.Shanghai Engineering Research Center of Pharmaceutical Process, Shanghai 201203
Published: 2025-11-10 doi: 10.16522/j.cnki.cjph.2025.11.005
Outline
收藏切换

The synthetic process of asciminib hydrochloride, a drug for treating chronic myeloid leukemia, was optimized. Methyl 5-bromo-6-chloronicotinate (2) was used as the starting material and condensed with (R)-pyrrolidin-3-ol (3) to generate methyl (R)-5-bromo-6- (3-hydroxypyrrolidin-1-yl) nicotinate (4). Compound 4 was subjected to Suzuki coupling reaction with 1- (tetrahydro-2H-pyran-2-yl)-1H-pyrazole-5-boronic acid pinacol ester to produce methyl 6-[ (R)-3-hydroxypyrrolidin-1-yl]-5-[1- (tetrahydro-2H-pyran-2-yl)-1H-pyrazol-5-yl] nicotinate (6). Compound 6 was coupled with 4- (chlorodifluoromethoxy) aniline to produce (R)-5-[1- (tetrahydro-2H-pyran-2-yl)-1H-pyrazol-5-yl]-N-[4- (chlorodifluoromethoxy)phenyl]-6- (3-hydroxypyrrolidin-1-yl) nicotinamide (8). Then compound 8 was deprotected to obtain free base of asciminib (1), while 1 was finally salified to obtain asciminib hydrochloride. Overall yield was 39.27% (based on 2) with purity of 99.89% and ee value of 99.88%. The optimized synthesis process of asciminib hydrochloride has mild conditions, controllable quality, and simple operation, which is suitable for industrial production.

asciminib  /  chronic myeloid leukemia  /  antineoplastics  /  synthetic process  /  Suzuki coupling
鲁新宇, 周阳, 夏兆萍, 王冠. 盐酸阿思尼布的合成工艺优化. 中国医药工业杂志, 2025 , 56 (11) : 1398 -1403 . DOI: 10.16522/j.cnki.cjph.2025.11.005
Xinyu LU, Yang ZHOU, Zhaoping XIA, Guan WANG. Optimized Synthesis of Asciminib Hydrochloride[J]. Chinese Journal of Pharmaceuticals, 2025 , 56 (11) : 1398 -1403 . DOI: 10.16522/j.cnki.cjph.2025.11.005
Year 2025 volume 56 Issue 11
31
9
Cite this Article
BibTeX
Article Info
doi: 10.16522/j.cnki.cjph.2025.11.005
  • Receive Date:2025-04-25
  • Online Date:2026-11-18
  • Published:2025-11-10
Article Data
Affiliations
History
  • Received:2025-04-25
Affiliations
    1.National Key Lab. of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry Co., Ltd., Shanghai 201203
    2.China State Institute of Pharmaceutical Industry, Shanghai 201203
    3.Shanghai Engineering Research Center of Pharmaceutical Process, Shanghai 201203
References
Share
https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2025.11.005
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT